You have 9 free searches left this month | for more free features.

Mitoxantrone

Showing 1 - 25 of 375

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Relapsing Multiple Sclerosis Trial in Beijing (Mitoxantrone Hydrochloride Liposome Injection)

Not yet recruiting
  • Relapsing Multiple Sclerosis
  • Mitoxantrone Hydrochloride Liposome Injection
  • Beijing, Beijing, China
    Xuanwu Hospital Capital Medical University
Aug 9, 2022

Neuromyelitis Optica Spectrum Disorder Trial (Mitoxantrone Hydrochloride Liposome Injection)

Not yet recruiting
  • Neuromyelitis Optica Spectrum Disorder
  • Mitoxantrone Hydrochloride Liposome Injection
  • (no location specified)
Sep 20, 2022

Lymphoma, Solid Tumors Trial in Guangzhou (Mitoxantrone Hydrochloride Liposome)

Recruiting
  • Lymphoma, Solid Tumors
  • Mitoxantrone Hydrochloride Liposome
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 14, 2022

Advanced Solid Tumor Trial (Mitoxantrone Hydrochloride Liposome injection, Capecitabine, Albumin-paclitaxel)

Not yet recruiting
  • Advanced Solid Tumor
  • Mitoxantrone Hydrochloride Liposome injection
  • +2 more
  • (no location specified)
Apr 18, 2022

Relapsed or Refractory Multiple Myeloma Trial in Beijing (Mitoxantrone Hydrochloride Liposome injection, Bortezomib for

Recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Mitoxantrone Hydrochloride Liposome injection
  • +2 more
  • Beijing, Beijing, China
    Beijing Chaoyang Hospital, Capital Medical University
Jan 16, 2022

Relapsed or Refractory Acute Myeloid Leukemia (AML) Trial (Mitoxantrone Hydrochloride Liposome)

Not yet recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia (AML)
  • Mitoxantrone Hydrochloride Liposome
  • (no location specified)
Apr 19, 2022

Recurrent/Refractory Lymphoma Trial in Guiyang (Mitoxantrone Hydrochloride Liposome Injection)

Completed
  • Recurrent/Refractory Lymphoma
  • Mitoxantrone Hydrochloride Liposome Injection
  • Guiyang, Guizhou, China
    Guizhou Cancer Hospita
Dec 12, 2021

Advanced Pancreatic Cancer Trial (Mitoxantrone Hydrochloride Liposome injection)

Not yet recruiting
  • Advanced Pancreatic Cancer
  • Mitoxantrone Hydrochloride Liposome injection
  • (no location specified)
Oct 19, 2021

Advanced Malignant Tumor Trial (Mitoxantrone Hydrochloride Liposome)

Not yet recruiting
  • Advanced Malignant Tumor
  • Mitoxantrone Hydrochloride Liposome
  • (no location specified)
Oct 9, 2021

Non Hodgkin Lymphoma Trial (Liposomal Mitoxantrone Hydrochloride dose level 1, Liposomal Mitoxantrone Hydrochloride dose level

Not yet recruiting
  • Non Hodgkin Lymphoma
  • Liposomal Mitoxantrone Hydrochloride dose level 1
  • +6 more
  • (no location specified)
Mar 17, 2022

Peripheral T Cell Lymphoma Trial in Zhejiang (Mitoxantrone liposome?Chidamide?Azacitidine)

Recruiting
  • Peripheral T Cell Lymphoma
  • Mitoxantrone liposome、Chidamide、Azacitidine
  • Zhejiang, Zhejiang, China
    Second Affiliated Hospital, School of Medicine, Zhejiang Univers
Aug 9, 2022

Diffuse Large B-cell Lymphoma Trial in Wuhan (Mitoxantrone Hydrochloride Liposome, Rituximab, Lenalidomide)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • Mitoxantrone Hydrochloride Liposome
  • +2 more
  • Wuhan, Hubei, China
    Department of Hematology Tongji Hospital, Tongji Medical College
Oct 7, 2022

Acute Myeloid Leukemia Trial in Pittsburgh (mitoxantrone + etoposide + gemtuzumab ozogamicin)

Recruiting
  • Acute Myeloid Leukemia
  • mitoxantrone + etoposide + gemtuzumab ozogamicin
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Feb 9, 2022

Treatment, Peripheral T-cell Lymphoma Trial in Beijing (liposomal mitoxantrone HCl, gemcitabine, dexamethasone, and cisplatin)

Recruiting
  • Treatment
  • Peripheral T-cell Lymphoma
  • liposomal mitoxantrone hydrochloride, gemcitabine, dexamethasone, and cisplatin
  • Beijing, China
  • +4 more
Jun 28, 2022

Prostate Cancer Patients Trial in Qingdao, Shanghai (Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin)

Recruiting
  • Prostate Cancer Patients
  • Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin
  • Qingdao, Shandong, China
  • +1 more
May 3, 2022

Treatment-naïve, Peripheral T Cell Lymphoma Trial in Guangzhou (Dose-finding stage: Liposomal mitoxantrone HCl,

Recruiting
  • Treatment-naïve
  • Peripheral T Cell Lymphoma
  • Dose-finding stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone
  • Dose-expansion stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jul 26, 2021

Extranodal Natural Killer T Cell Lymphoma Trial in China (Tislelizumab combined with Liposomal mitoxantrone HCl, Maintenance of

Recruiting
  • Extranodal Natural Killer T Cell Lymphoma
  • Tislelizumab combined with Liposomal mitoxantrone hydrochloride
  • Maintenance of tislelizumab
  • Beijing, China
  • +5 more
Jul 15, 2022

Advanced Solid Tumors Trial in Baoding (Mitoxantrone Hydrochloride Liposome injection)

Not yet recruiting
  • Advanced Solid Tumors
  • Mitoxantrone Hydrochloride Liposome injection
  • Baoding, Hebei, China
    Affiliated Hospital of Hebei University
Jun 4, 2021

Acute Myeloid Leukemia Trial (Gilteritinib 40 MG Oral Tablet, Cladribine, Cytarabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Gilteritinib 40 MG Oral Tablet
  • +4 more
  • (no location specified)
Apr 8, 2022

Treatment-naive or Relapsed or Refractory Acute Myeloid Leukemia (AML) Trial in Guiyang (Mitoxantrone Hydrochloride liposome

Not yet recruiting
  • Treatment-naive or Relapsed or Refractory Acute Myeloid Leukemia (AML)
  • Mitoxantrone Hydrochloride liposome injection
  • Cytarabine (LoDAC)
  • Guiyang, Guizhou, China
    The Affiliated Hospital of Guizhou Medical University
Oct 19, 2021

Unresectable or Metastatic Bone and Soft Tissue Sarcoma Trial (Mitoxantrone Hydrochloride Liposome Injection)

Not yet recruiting
  • Unresectable or Metastatic Bone and Soft Tissue Sarcoma
  • Mitoxantrone Hydrochloride Liposome Injection
  • (no location specified)
May 20, 2021

Recurrent Head Neck Cancer, Metastatic Head Neck Cancer Trial (Mitoxantrone Hydrochloride Liposome, intravenous injection (IV))

Not yet recruiting
  • Recurrent Head and Neck Cancer
  • Metastatic Head and Neck Cancer
  • Mitoxantrone Hydrochloride Liposome, intravenous injection (IV)
  • (no location specified)
May 20, 2021

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoblastic Lymphoma Trial in Valhalla, Charlotte (Clofarabine,

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Valhalla, New York
  • +1 more
Oct 29, 2021

Advanced Solid Tumor Trial in China (Mitoxantrone Hydrochloride Liposome, intravenous injection (IV))

Active, not recruiting
  • Advanced Solid Tumor
  • Mitoxantrone Hydrochloride Liposome, intravenous injection (IV)
  • Bengbu, Anhui, China
  • +7 more
Oct 28, 2021

Peripheral T Cell Lymphoma Trial in Guangzhou (Mitoxantrone Hydrochloride Liposome Injection, Chidamide)

Not yet recruiting
  • Peripheral T Cell Lymphoma
  • Mitoxantrone Hydrochloride Liposome Injection
  • Chidamide
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Dec 11, 2020